Study on the Effects of Rifaximin on Stress and Fear Responses in Healthy Men
- Substances:Rifaximin
Belgium- Participants:18–64 years · Healthy volunteers
- Substances:Rifaximin
- Sponsor:UZ Leuven
Rare diseases
Investigational molecules
Locations
Back to Belgium1 973 clinical trials in Brasschaat, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.
BelgiumStudy on the Effects of Naloxegol and Codeine on Opioid-Induced Constipation in Healthy Volunteers
BelgiumStudy on Pain and Usability of Rabies Vaccine Injection Techniques in Children Aged 4-14 Using Inactivated Rabies Virus (Strain Flury LEP)
BelgiumStudy on the Effectiveness of Durvalumab and BCG in Treating High-Risk, Non-Muscle Invasive Bladder Cancer in Patients New to BCG Treatment
BelgiumStudy on the Safety and Immune Response of a 21-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers
BelgiumStudy on the 9vHPV Vaccine for Preventing Oral HPV Infections in Men Aged 20-45
BelgiumStudy Comparing Intradermal and Intramuscular Rabies Vaccine Doses in Adults
BelgiumStudy on the Effects of Doxycycline for Preventing Antibiotic Resistance in Patients with Bacterial STDs (Chlamydia, Gonorrhea, Syphilis)
BelgiumStudy on the Effects of Tobevibart and Elebsiran Compared to Bulevirtide for Patients with Chronic Hepatitis D Virus Infection
BelgiumStudy on the Effects of Liraglutide on Hunger and Digestion in Obese Patients
BelgiumStudy Comparing Intradermal and Intramuscular Rabies Vaccination with Inactivated Rabies Virus for Patients Needing a Booster Dose
BelgiumStudy on How Apixaban and Teduglutide Affect Patients with Short Bowel Syndrome on Long-Term Parenteral Nutrition
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking clinical trials focusing on lung cancer treatments, including studies of novel therapies for both non-small cell and small cell lung cancer. Several trials are evaluating innovative combination therapies and targeted treatments for patients with specific genetic markers.
Multiple trials investigating new treatments for breast cancer, particularly focusing on hormone receptor-positive and HER2-negative subtypes. Research includes evaluation of novel therapeutic approaches and comparative studies of different treatment regimens.
Comprehensive studies in multiple myeloma and other blood disorders, investigating new therapeutic options and treatment combinations. Trials include evaluation of novel agents for both newly diagnosed and relapsed/refractory cases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.